LMS Compliance Ltd. (SGX:LMS)

Intra-Cellular Therapies Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	25.38	20.9	18.68	16.99	15.84
Revenue Growth (YoY)	21.44%	11.92%	9.94%	7.25%	9.04%
Cost of Revenue	12.06	10.44	8.79	7.85	7.72
Gross Profit	13.32	10.47	9.89	9.14	8.12
Selling, General & Admin	0.25	0.25	0.12	0.07	0.04
Other Operating Expenses	3.76	2.25	2.01	1.69	1.29
Operating Expenses	5.14	3.76	3.24	2.74	2.22
Operating Income	8.18	6.7	6.65	6.4	5.9
Interest Expense	-0.19	-0.18	-0.21	-0.23	-0.26
Interest & Investment Income	0.2	0.21	0.05	0.23	0.15
Earnings From Equity Investments	0.06	-	-	-	-
Currency Exchange Gain (Loss)	-0.65	0.72	-0	-	-0
Other Non Operating Income (Expenses)	0.11	0.01	0.09	-	0.01
EBT Excluding Unusual Items	7.71	7.46	6.58	6.4	5.79
Impairment of Goodwill	-	-	-	-	-0.04
Gain (Loss) on Sale of Investments	-0.05	0.06	0.08	-	-0.03
Gain (Loss) on Sale of Assets	0.12	0.05	-	0.01	-
Asset Writedown	-0.01	-0.01	-0.02	-0.03	-0
Other Unusual Items	0.04	0.03	-4.22	0.24	0.47
Pretax Income	7.81	7.59	2.41	6.61	6.19
Income Tax Expense	2.6	2.11	1.69	1.66	1.5
Net Income	5.21	5.48	0.72	4.95	4.69
Net Income to Common	5.21	5.48	0.72	4.95	4.69
Net Income Growth	-4.98%	661.25%	-85.45%	5.50%	18.84%
Shares Outstanding (Basic)	105	105	88	86	87
Shares Outstanding (Diluted)	105	105	88	86	87
Shares Change (YoY)	-	19.39%	2.42%	-1.46%	-
EPS (Basic)	0.05	0.05	0.01	0.06	0.05
EPS (Diluted)	0.05	0.05	0.01	0.06	0.05
EPS Growth	-4.98%	537.67%	-85.80%	7.06%	18.84%
Free Cash Flow	3.53	4.9	1.7	4.49	5.79
Free Cash Flow Per Share	0.03	0.05	0.02	0.05	0.07
Dividend Per Share	0.036	0.010	0.004	-	-
Dividend Growth	256.82%	146.34%	-	-	-
Gross Margin	52.48%	50.07%	52.94%	53.80%	51.26%
Operating Margin	32.22%	32.07%	35.61%	37.68%	37.23%
Profit Margin	20.52%	26.22%	3.85%	29.13%	29.61%
Free Cash Flow Margin	13.91%	23.45%	9.09%	26.40%	36.54%
EBITDA	9.14	7.58	7.46	7.05	6.43
EBITDA Margin	35.99%	36.28%	39.94%	41.51%	40.61%
D&A For EBITDA	0.96	0.88	0.81	0.65	0.54
EBIT	8.18	6.7	6.65	6.4	5.9
EBIT Margin	32.22%	32.07%	35.61%	37.68%	37.23%
Effective Tax Rate	33.30%	27.82%	70.15%	25.14%	24.28%
Advertising Expenses	0.22	0.22	0.09	0.04	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.